BRIEF-Roche Diagnostics Says Receives Health Canada Authorization To Market Cobas Hpv On Cobas 6800/8800 Systems For Cervical Cancer Screening In Canada

1 Min Read

Jan 31 (Reuters) - Roche Holding AG:

* ROCHE DIAGNOSTICS - RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET COBAS HPV ON COBAS 6800/8800 SYSTEMS FOR CERVICAL CANCER SCREENING IN CANADA. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below